Goldman Sachs Group Inc Amneal Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 937,189 shares of AMRX stock, worth $6.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
937,189
Previous 937,189 -0.0%
Holding current value
$6.76 Million
Previous $7.85 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$7.72 - $9.01 $282,212 - $329,369
-36,556 Reduced 3.75%
937,189 $7.85 Million
Q4 2024

Feb 11, 2025
BUY
$7.69 - $9.25 $922,384 - $1.11 Million
119,946 Added 14.05%
973,745 $7.71 Million
Q3 2024

Nov 14, 2024
SELL
$6.42 - $8.83 $3.38 Million - $4.65 Million
-526,613 Reduced 38.15%
853,799 $7.1 Million
Q2 2024

Aug 13, 2024
BUY
$5.36 - $7.11 $3.69 Million - $4.89 Million
687,926 Added 99.34%
1,380,412 $8.77 Million
Q1 2024

May 15, 2024
BUY
$5.24 - $6.34 $1.86 Million - $2.25 Million
355,215 Added 105.32%
692,486 $4.2 Million
Q4 2023

Feb 13, 2024
SELL
$3.36 - $6.21 $2.61 Million - $4.83 Million
-777,682 Reduced 69.75%
337,271 $2.05 Million
Q3 2023

May 14, 2024
BUY
$2.76 - $4.59 $2.15 Million - $3.57 Million
777,682 Added 230.58%
1,114,953 $4.71 Million
Q3 2023

Nov 14, 2023
BUY
$2.76 - $4.59 $1.37 Million - $2.28 Million
496,781 Added 80.36%
1,114,953 $4.71 Million
Q2 2023

May 14, 2024
BUY
$1.33 - $3.1 $23,634 - $55,087
17,770 Added 2.96%
618,172 $1.92 Million
Q2 2023

Aug 14, 2023
BUY
$1.33 - $3.1 $23,634 - $55,087
17,770 Added 2.96%
618,172 $1.92 Million
Q1 2023

May 14, 2024
SELL
$1.27 - $2.7 $83,778 - $178,110
-65,967 Reduced 9.9%
600,402 $834,000
Q1 2023

May 11, 2023
SELL
$1.27 - $2.7 $83,778 - $178,110
-65,967 Reduced 9.9%
600,402 $834,000
Q4 2022

May 14, 2024
BUY
$1.96 - $2.61 $101,898 - $135,691
51,989 Added 8.46%
666,369 $1.33 Million
Q4 2022

Feb 13, 2023
BUY
$1.96 - $2.61 $101,898 - $135,691
51,989 Added 8.46%
666,369 $1.33 Million
Q3 2022

May 14, 2024
SELL
$2.02 - $3.62 $271,235 - $486,075
-134,275 Reduced 17.94%
614,380 $1.24 Million
Q3 2022

Nov 10, 2022
SELL
$2.02 - $3.62 $271,235 - $486,075
-134,275 Reduced 17.94%
614,380 $1.24 Million
Q2 2022

May 14, 2024
BUY
$3.01 - $4.46 $1.24 Million - $1.83 Million
411,384 Added 121.97%
748,655 $2.38 Million
Q2 2022

Aug 15, 2022
SELL
$3.01 - $4.46 $106,635 - $158,004
-35,427 Reduced 4.52%
748,655 $2.38 Million
Q1 2022

May 16, 2022
SELL
$3.9 - $4.89 $778,884 - $976,601
-199,714 Reduced 20.3%
784,082 $3.27 Million
Q4 2021

Feb 14, 2022
BUY
$3.95 - $5.85 $170,505 - $252,521
43,166 Added 4.59%
983,796 $4.71 Million
Q3 2021

Nov 10, 2021
BUY
$4.31 - $5.64 $4.05 Million - $5.31 Million
940,630 New
940,630 $5.02 Million

Others Institutions Holding AMRX

# of Institutions
244
Shares Held
136M
Call Options Held
302K
Put Options Held
103K
View Full List

About Amneal Pharmaceuticals, Inc.

AMRX Quotes by TradingView
  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.09B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email